EV-based Diagnostics, Delivery & Therapeutics
Date: February 17 - 18, 2020
Venue: Coronado Island Marriott Resort & Spa, Coronado Island, California USA
Michael Graner
Associate Professor, University of Colorado Anschutz School of Medicine
Chulhee Choi
Professor and Chair, BioMedical Imaging Center, Korea Advanced Institute of Science and Technology (KAIST), President, ILIAS Biologics Incorporated
Paul Robbins
Professor, Department of Biochemistry, Molecular Biology, and Biophysics, and the Institute on the Biology of Aging and Metabolism, University of Minnesota Medical School
Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas, Adjunct Professor, Ulsan National Institute of Science & Technology
Lucia Languino
Professor of Cancer Biology, Thomas Jefferson University
Susanne Gabrielsson
Professor, Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet
Samir EL-Andaloussi
Associate Professor, Karolinska Institutet
Aijun Wang
Associate Professor, Director of Translational Research, Innovation and Entrepreneurship, University of California-Davis
Lorraine O'Driscoll
Professor in Pharmacology, Trinity College Dublin
Staff Clinician, Molecular Immunogenetics & Vaccine Research Section, National Cancer Institute (NCI)
Dana Larocca
VP Discovery Research, AgeX Therapeutics
Steven Stice
Co-Founder and Chief Scientific Officer, Aruna Bio; DW Brook Distinguished Professor and Director of the Regenerative Bioscience Center, Georgia Research Alliance Eminent Scholar, University of Georgia
Raghu Kalluri
Professor & Chairman, Department of Cancer Biology; Olla S. Stribling Distinguished Chair for Cancer Research, MD Anderson Cancer Center
Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands
Mei He
Assistant Professor, University of Kansas
Jan Lotvall
Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles
Dolores Di Vizio
Professor, Cedars Sinai Medical Center
SelectBIO EV-based Diagnostics, Delivery & Therapeutics 2020 Conference brings together the most up-to-date technologies and advances in this expanding and evolving field. Our coverage in this conference focuses on the various research efforts and applications of Exosomes/Extracellular Vesicles (EVs) in the following major topic areas:
Extracellular Vesicles (EVs): Exosomes and Microvesicles -- Research Activities
Exosome/EV Engineering -- Engineered Exosomes for Delivery
Drug Delivery via Engineered Vesicles
Exosomes/EV-based Therapeutics Development
This conference features an international faculty of speakers from academia as well as industry addressing the following topic areas:
Technologies for Isolation and Characterization: Single Vesicle Analysis Approaches
Role in Cancer and Various Disease Classes
Biomarker Potential for Diagnostics Development
Therapeutics Potential and Technology Advances in the EV Field as well as Drug Delivery and Therapeutics Development
The ability to engineer EVs and the ability of EVs to target specific sites offers the ability to tailor therapeutics with "exquisite targeting ability" and opens up a whole new class of therapeutics which are classified as biologicals and which do not have the side effects and toxicity associated with small molecule-based therapies.
This conference explores this topic and takes a deep dive into the technology platforms, diseases targeted and clinical results-to-date.
Registered delegates receive access to the co-located concurrent conference tracks, the co-located exhibit hall featuring companies from around the world providing tools/technologies, products and services.
Conference Presentations and Content Organization
Circulating Biomarkers 2020
EV-based Diagnostics, Delivery and Therapeutics 2020
EVs and Stem Cells Summit 2020 -- Speakers from this Track are in the Two Co-Located Tracks
Poster Submission Deadline: 31 January 2020
Engineered Exosomes and Extracellular Vesicles (EVs) for Delivery
Engineering EVs as Biologic Drugs
Ex Vivo Production of Large Quantities of EVs: Challenges and Opportunities
Exosomes-based Diagnostics/Liquid Biopsy Development
Diagnostics Markers Carried by Exosomes
Liquid Biopsy Enabled by Analyzing Exosomes
Exosomes/EVs-based Drug Delivery
Flow Cytometry and Single EV Analysis: A New Paradigm in Exosomes/EV Research
Stem Cell-based EVs for Regenerative Medicine
Tom Anchordoquy, Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Fatah Kashanchi, Professor, George Mason University
Aurelio Lorico, Professor of Pathology, Touro University Nevada
My Mahoney, Associate Professor, Thomas Jefferson University
Juliane Nguyen, Associate Professor, University of North Carolina at Chapel Hill
Robert Raffai, Professor, University of California-San Francisco
Davide Trotti, Professor, Scientific Director, Weinberg ALS Center, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University
Kendall Van Keuren-Jensen, Associate Professor, Translational Genomics Research Institute
William Whitford, Strategic Solutions Leader, GE Healthcare Life Sciences
Andries Zijlstra, Associate Professor of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center
Event Information updated
Speaker,Sponsor updated
© Select Biosciences 2019, All Rights Reserved | Global Information, Inc. - International Marketing Partner of EV-based Diagnostics, Delivery & Therapeutics